• New Drugs Approved
    • 2024 Approvals
    • 2023 Approvals
  • Health and Medical Research News
    • Arthritis
    • Bronchitis
    • Cancer
    • Diabetes
    • Eye
    • Heart Conditions
    • Vaccines and Infections
    • Mental Health
    • Neurology
    • Pain Conditions
    • Skin Conditions
    • Stomach & Intestine
New FDA-Approved Treatment for Catheter-Related Infections: Defencath Approved on November 15th 2023

New FDA-Approved Treatment for Catheter-Related Infections: Defencath Approved on November 15th 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is Defencath prescribed for?  Defencath is prescribed to reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter. What is Defencath and what does it do?...
FDA Approves Fruzaqla: A New Hope for Metastatic Colorectal Cancer Patients, Approved November 8, 2023

FDA Approves Fruzaqla: A New Hope for Metastatic Colorectal Cancer Patients, Approved November 8, 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is Fruzaqla prescribed for? Fruzaqla is prescribed for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if...
FDA Approves Loqtorzi for Advanced Nasopharyngeal Cancer on October 26, 2023

FDA Approves Loqtorzi for Advanced Nasopharyngeal Cancer on October 26, 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is Loqtorzi prescribed for? Loqtorzi is prescribed to treat recurrent or metastatic nasopharyngeal carcinoma when used together with or following other therapies. What is Loqtorzi and what does it do? Loqtorzi, pronounced lok-tor-zee, (generic name: vonoprazan)...
FDA Approves Omvoh for Ulcerative Colitis Treatment: A New Solution as of October 26, 2023

FDA Approves Omvoh for Ulcerative Colitis Treatment: A New Solution as of October 26, 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is Omvoh prescribed for?    Omvoh is prescribed for the treatment of moderately to severely active ulcerative colitis in adults. What is Omvoh and what does it do? Omvoh, pronounced ahm-VOH, (generic name: mirikizumab-mrkz) is a medication recently...
FDA Greenlights Agamree for Duchenne Muscular Dystrophy on October 26, 2023

FDA Greenlights Agamree for Duchenne Muscular Dystrophy on October 26, 2023

by B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals, Trending News

What is Agamree prescribed for?   Agamree is prescribed for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. What is Agamree and what does it do? Agamree,  pronounced ah gam’ ree, (generic name: vamorolone),...
Page 15 of 22« First«...10...1314151617...20...»Last »

Latest Posts

  • Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses
  • Do All Men with Prostate Cancer Get the Same Treatment? A Look at Racial and Ethnic Gaps
  • New Light on Osteoarthritis: Innovative Imaging Techniques Unveil Early Joint Damage
  • New Combination Therapy Shows Promise for Advanced Urinary Tract Cancer
  • New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis

ScienceMyHealth is a product of iSimcha.

Navigate

HomePage

Blog

 

Company

About Us

Contact Us

© 2025 iSimcha

Privacy Policy

Terms of Service